These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 21910571

  • 1. New target therapies for patients with neuroendocrine tumors of the pancreas.
    Baltogiannis G, Katsios C, Roukos DH.
    Expert Rev Gastroenterol Hepatol; 2011 Oct; 5(5):563-6. PubMed ID: 21910571
    [No Abstract] [Full Text] [Related]

  • 2. Oral agents for treatment of patients with advanced pancreatic neuroendocrine tumors: could pharmaeconomic, cost-effectiveness data play a significant role?
    Barna ME, Uomo I, Pastorello M.
    JOP; 2013 Jan 10; 14(1):102-4. PubMed ID: 23306347
    [No Abstract] [Full Text] [Related]

  • 3. Advances in pancreatic neuroendocrine tumor treatment.
    van der Veldt AA, Kleijn SA.
    N Engl J Med; 2011 May 12; 364(19):1873; author reply 1873-5. PubMed ID: 21561355
    [No Abstract] [Full Text] [Related]

  • 4. Promising advances in the treatment of malignant pancreatic endocrine tumors.
    Jensen RT, Delle Fave G.
    N Engl J Med; 2011 Feb 10; 364(6):564-5. PubMed ID: 21306243
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recent studies show promise for treating rare pancreatic tumors.
    Peres J.
    J Natl Cancer Inst; 2011 Apr 20; 103(8):624-7. PubMed ID: 21474831
    [No Abstract] [Full Text] [Related]

  • 7. Targeted agents in treatment of neuroendocrine tumors of pancreas.
    Karampelas IN, Syrigos KN, Saif MW.
    JOP; 2014 Jul 28; 15(4):351-3. PubMed ID: 25076341
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of everolimus vs sunitinib in treating patients with advanced, progressive pancreatic neuroendocrine tumors in the United States.
    Casciano R, Chulikavit M, Perrin A, Liu Z, Wang X, Garrison LP.
    J Med Econ; 2012 Jul 28; 15 Suppl 1():55-64. PubMed ID: 22881362
    [Abstract] [Full Text] [Related]

  • 12. Advances in the treatment of pancreatic neuroendocrine tumours.
    Gao F, Visvardis EE, Sita-Lumsden A, Waxman J.
    QJM; 2012 Sep 28; 105(9):819-22. PubMed ID: 22383691
    [Abstract] [Full Text] [Related]

  • 13. Everolimus and sunitinib: from mouse models to treatment of pancreatic neuroendocrine tumors.
    Liakakos T, Roukos DH.
    Future Oncol; 2011 Sep 28; 7(9):1025-9. PubMed ID: 21919689
    [No Abstract] [Full Text] [Related]

  • 14. Translational medicine: Cancer lessons from mice to humans.
    Tuveson D, Hanahan D.
    Nature; 2011 Mar 17; 471(7338):316-7. PubMed ID: 21412332
    [No Abstract] [Full Text] [Related]

  • 15. [Current status and therapeutic strategy for pancreatic neuroendocrine tumors in Japan].
    Ito T, Igarashi H, Jensen RT, Takayanagi R.
    Fukuoka Igaku Zasshi; 2012 Jul 17; 103(7):131-7. PubMed ID: 22978065
    [No Abstract] [Full Text] [Related]

  • 16. Systemic therapy for advanced pancreatic neuroendocrine tumors.
    Kulke MH.
    Semin Oncol; 2013 Feb 17; 40(1):75-83. PubMed ID: 23391115
    [Abstract] [Full Text] [Related]

  • 17. Pancreatic neuroendocrine tumors: signal pathways and targeted therapies.
    Peng L, Schwarz RE.
    Curr Mol Med; 2013 Mar 17; 13(3):333-9. PubMed ID: 23331005
    [Abstract] [Full Text] [Related]

  • 18. A shining light in the darkness for the treatment of pancreatic neuroendocrine tumors.
    Capdevila J, Tabernero J.
    Cancer Discov; 2011 Aug 17; 1(3):213-21. PubMed ID: 22586573
    [Abstract] [Full Text] [Related]

  • 19. Pancreatic neuroendocrine tumors: role of novel agents. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Strimpakos AS, Syrigos KN, Saif MW.
    JOP; 2011 Mar 09; 12(2):117-9. PubMed ID: 21386634
    [Abstract] [Full Text] [Related]

  • 20. [Erlotinib, sunitinib, and everolimus].
    Takahashi M.
    Nihon Rinsho; 2015 Mar 09; 73 Suppl 3():409-13. PubMed ID: 25857058
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.